C12Y 201/0102
Glycine n-methyltransferase
Official title: Glycine N-methyltransferase (2.1.1.20)
C12Y201/0102 (Glycine n-methyltransferase) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 5
- Assignees
- 4
- Inventors
- 10
- Latest grant
- 29 Oct 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Cysteine prototrophy2 Oct 2025US 2025/0304911 A1Pfizer Inc.
- Methods for Treating Cancer That Has A Phosphatidylinositol 3,4,5-Trisphosphate Rac Exchange Factor 2 (PREX2) Protein Expressed Thereon29 Dec 2022US 2022/0409704 A1Kaohsiung Medical University
- Method for determining, predicting and treating cancer6 Feb 2020US 2020/0040401 A1Kaohsiung Medical University
- Methods and compositions to treat liver diseases and conditions30 Aug 2018US 2018/0245080 A1AsociacióN Centro De InvestigacióN Cooperativa En Biociencias-Cic Biogune
- Using GNMT as a Novel Therapeutic or Preventing Agent for Fatty Liver Related Diseases8 May 2014US 2014/0127182 A1National Yang-Ming University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.